More TOPCAT flaws back spironolactone’s HFpEF efficacy

ORLANDO – Spironolactone inched a little closer toward becoming the first and only agent with proven efficacy for treating patients with heart failure with preserved ejection fraction based on...
Source: Hospitalist News - Category: Hospital Management Source Type: research